Shouting doctors shun debate Health Canada considers bamlanivimab and etesevimab combination for COVID-19 IV monoclonal antibodies recently received US Emergency Use Authorization for treatment of mild to moderate COVID-19 in high-risk outpatients. Meme of the week: Hanging out with the hospital pharmacist Virtual care and the great uncoupling: The change, the debt and the way forward London Drugs using Medimap platform to provide virtual consultations with doctors in-pharmacy Tech injection training ramps up Doctors and depression Doctors, caregivers push for in home COVID-19 vaccinations for housebound senior 'Get into arms': Pharmacists ready to roll out the vaccine in Ontario Nominate your Pharmacy Champion Health Canada approves AstraZeneca's COVID-19 vaccine Manitoba deadline looms for implementing Safety IQ First Previous 594 595 596 597 598 Next Last
